Vusala Asadova1, Zulfiye Gul2, Rifat Levent Buyukuysal3, Ozgur Yalcinbayir4. 1. Department of Ophthalmology, Zarifa Aliyeva Adına Milli Oftalmoloji Merkez, Baku, Azerbaijan. 2. Department of Medical Pharmacology, Faculty of Medicine, Bahcesehir University, Sahrayi Cedid Mahallesi Batman Sokak No: 66-68 Yenisahra/Kadikoy, 34743, Istanbul, Turkey. zulfiye.gul@med.bau.edu.tr. 3. Department of Pharmacology, Uludag University School of Medicine, Bursa, Turkey. 4. Department of Ophthalmology, Uludag University School of Medicine, Bursa, Turkey.
Abstract
PURPOSE: To assess the vitreous and serum levels of neuron-specific enolase (NSE), S100B and malondialdehyde (MDA) in proliferative diabetic retinopathy (PDR) cases and investigate the correlation between preoperative and postoperative anatomical and clinical features. MATERIALS AND METHODS: The study group included patients who had pars plana vitrectomy (PPV) for PDR. The control group included non-diabetic individuals who underwent PPV surgery for vitreoretinal interface disorders. Samples of serum were taken from all participants preoperatively, while vitreous samples were taken during the PPV. Vitreous and serum levels of NSE, S100B and MDA were measured, and comparisons were made between the groups. RESULTS: The study group consisted of 56 eyes of 56 cases with PDR. The control group consisted of 20 eyes of 20 cases. The concentrations of vitreous NSE, S100B and MDA were significantly higher than the control group (p < 0.0001, p < 0.05, p < 0.001, respectively). Serum levels were statistically different for NSE and S100B (p < 0.05). CONCLUSION: Our results clearly show that vitreous levels of S100B, NSE and MDA and serum concentrations of NSE and S100B increased significantly in patients with PDR. The findings may possibly indicate neurodegeneration and oxidative stress; therefore, these markers may have a diagnostic value in patients with PDR.
PURPOSE: To assess the vitreous and serum levels of neuron-specific enolase (NSE), S100B and malondialdehyde (MDA) in proliferative diabetic retinopathy (PDR) cases and investigate the correlation between preoperative and postoperative anatomical and clinical features. MATERIALS AND METHODS: The study group included patients who had pars plana vitrectomy (PPV) for PDR. The control group included non-diabetic individuals who underwent PPV surgery for vitreoretinal interface disorders. Samples of serum were taken from all participants preoperatively, while vitreous samples were taken during the PPV. Vitreous and serum levels of NSE, S100B and MDA were measured, and comparisons were made between the groups. RESULTS: The study group consisted of 56 eyes of 56 cases with PDR. The control group consisted of 20 eyes of 20 cases. The concentrations of vitreous NSE, S100B and MDA were significantly higher than the control group (p < 0.0001, p < 0.05, p < 0.001, respectively). Serum levels were statistically different for NSE and S100B (p < 0.05). CONCLUSION: Our results clearly show that vitreous levels of S100B, NSE and MDA and serum concentrations of NSE and S100B increased significantly in patients with PDR. The findings may possibly indicate neurodegeneration and oxidative stress; therefore, these markers may have a diagnostic value in patients with PDR.
Authors: Stefan Moritz; Jan Warnat; Sylvia Bele; Bernhard Martin Graf; Chris Woertgen Journal: J Neurosurg Anesthesiol Date: 2010-01 Impact factor: 3.956
Authors: Annal D Meleth; Elvira Agrón; Chi-Chao Chan; George F Reed; Kiran Arora; Gordon Byrnes; Karl G Csaky; Frederick L Ferris; Emily Y Chew Journal: Invest Ophthalmol Vis Sci Date: 2005-11 Impact factor: 4.799
Authors: Josy Augustine; Evan P Troendle; Peter Barabas; Corey A McAleese; Thomas Friedel; Alan W Stitt; Tim M Curtis Journal: Front Endocrinol (Lausanne) Date: 2021-02-18 Impact factor: 5.555